Ailing Wang

Title: Ailing Wang: Innovator in Pharmaceutical Chemistry

Introduction

Ailing Wang is a prominent inventor based in Beijing, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds that target neurotransmitter systems. With a total of 2 patents, her work has the potential to impact therapeutic approaches for various neurological conditions.

Latest Patents

Ailing Wang's latest patents include a glycine reuptake inhibitor and a norepinephrine and selective serotonin receptor blocker. The glycine reuptake inhibitor patent discloses a compound of formula I, which includes various groups such as hydrogen, halogen, and C1-6 alkyl. This compound aims to enhance glycine levels in the brain, potentially offering new treatment avenues. The norepinephrine and selective serotonin receptor blocker patent describes a compound that effectively blocks these receptors, which may lead to advancements in treating mood disorders and other related conditions.

Career Highlights

Throughout her career, Ailing Wang has worked with notable companies such as Beijing Medisan Technology Co., Ltd. and Harbin Medisan Pharmaceutical Co., Ltd. Her experience in these organizations has allowed her to refine her skills in drug development and innovation.

Collaborations

Ailing Wang has collaborated with esteemed colleagues, including Jinai Liu and Mingxin Wang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the pharmaceutical field.

Conclusion

Ailing Wang's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her role as a key figure in the industry. Her work continues to pave the way for advancements in therapeutic solutions.